专题：Diabetes, Cardiovascular Risks, and Lipoproteins

This cluster of papers focuses on the metabolic syndrome, its association with cardiovascular disease, diabetes, insulin resistance, obesity, and atherosclerosis. It includes studies on glucose metabolism, lifestyle interventions, and global prevalence of related conditions.
最新文献
Lipoprotein(a), Cholesterol, Triglyceride Levels, and Vulnerable Coronary Plaques

article Full Text OpenAlex

Global Variation in Lipoprotein(a) Levels Among Patients With Coronary Heart Disease

article Full Text OpenAlex

Concordance‐discordance between apolipoprotein B and lipid biomarkers in predicting 20‐year atherosclerotic cardiovascular disease risk: The ATTICA study (2002–2022)

article Full Text OpenAlex

Clearance of Hepatitis C Viremia During Direct‐Acting Antiviral Therapy Leads to Rapid Changes in Lipid and Lipoprotein Metabolism

article Full Text OpenAlex

Hypertension and diabetes screening uptake in adults aged 40–70 in Indonesia: a knowledge, attitudes, and practices study

article Full Text OpenAlex

Target Populations for Novel Triglyceride-Lowering Therapies

review Full Text OpenAlex

Triglyceride to high-density lipoprotein ratio as a predictor for 10-year cardiovascular disease in individuals with diabetes in Thailand

article Full Text OpenAlex

Comment on “Risk prediction score and equation for progression of arterial stiffness using Japanese longitudinal health examination data”

letter Full Text OpenAlex

Comparison of complete blood count parameters in different severity of proteinuria among patients with type 2 diabetes mellitus

letter Full Text OpenAlex

The ratio of triglycerides to total lipids in chylomicrons and extremely large VLDL, very large VLDL, large VLDL, medium VLDL, and small VLDL has a significant negative causal relationship with Coronary revascularization (ANGIO or CABG). A Mendelian randomization study.

preprint Full Text OpenAlex

近5年高被引文献
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

article Full Text OpenAlex 2037 FWCI711.666

2. Classification and Diagnosis of Diabetes:Standards of Care in Diabetes—2023

review Full Text OpenAlex 1582 FWCI89.601

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe

article Full Text OpenAlex 1007 FWCI152.897

Metabolic Syndrome: Updates on Pathophysiology and Management in 2021

review Full Text OpenAlex 959 FWCI54.78

2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2022

review Full Text OpenAlex 894 FWCI113.989

2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2024

review Full Text OpenAlex 693 FWCI62.53

Prevalence and Treatment of Diabetes in China, 2013-2018

article Full Text OpenAlex 644 FWCI42.006

IDF diabetes Atlas: Global estimates of undiagnosed diabetes in adults for 2021

article Full Text OpenAlex 632 FWCI92.761

Global epidemiology of dyslipidaemias

review Full Text OpenAlex 583 FWCI33.559

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

article Full Text OpenAlex 554 FWCI81.354